Cerebromicrovascular pathology in alzheimer’s disease compared to normal aging

Gerontology

Volumn 43, Issue 1-2, 1997, Pages 26-43

  De La Torre, Jack C ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer s disease; Brain capillaries; Cerebral blood flow; Cerebromicrovessels; Dementia; Glucose oxygen; Ultrastructure

Indexed keywords

ACETYLSALICYLIC ACID; APOLIPOPROTEIN E4; GLUCOSE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN;

AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN VASCULAR RESISTANCE; COGNITIVE DEFECT; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG USE; ELECTRON MICROSCOPY; GLUCOSE TRANSPORT; HEAD INJURY; HEMODYNAMICS; HOMEOSTASIS; HUMAN; IMMUNOCYTOCHEMISTRY; NEUROFIBRILLARY TANGLE; NUTRIENT; OXYGEN TRANSPORT; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; RISK; SENILE PLAQUE;

AGING; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; HUMANS; MICROCIRCULATION;

EID: 0031029508     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213834     Document Type: Article

References (155)

1. Evans DA, Funkenstein HH, Albert M, Scherr PA, Cook NR, Chown M, Hebert L, Hennekcns C, Taylor J: Prevalence of Alzheimer's disease in a community population of older persons: Higher than previously reported. JAMA 1989:262:2551-2556.
2. Ernst RL, Hay J W: The US economic and social costs of Alzheimer’s disease revisited. Am J Publ Health 1994;84:1261-1264.
3. Hay JW, Ernst RE: The economic costs of Alzheimer’s disease. Am J Publ Health 1987;77:1169-1175.
4. Ball MJ: Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with aging and dementia. Acta Neuropa-Ihol 1977;37:111-118.
5. Price JL, Davis PB, Morris JC, White DL: The distribution of tangles, plaques and related inimuno-histochemical markers in healthy aging and Alzheimer's disease. Neu-robiol Aging 1991; 12:295-312.
6. Mann DMA, Tucker C, Yates P: The topographic distribution of senile plaques and neurofibrillary tangles in the brains of non-demented persons of different age. Neuropathol Appl Neurobiol 1987; 13:123-139.
7. Crystal HA, Dickson D, Flud P, Masur D, Scott R, Mehler M, Mas-deu J, Kawas C, Aronson M, Wolf-son L: Clinicopathologic studies in dementia: Non-demented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988: 91:354-359.
8. Ulrich J: Alzheimer changes in non-demented patients younger than sixty five: Possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann Neurol 1985;17:273-277.
9. Langui D, Probst A, Ulrich J: Alzheimer's changes in non-demented and demented patients: A statistical approach to their relationships. Acta Neuropathol 1995;89:57-62.
10. Armstrong RA, Myers D, Smith CU, Cairns N, Luthert PJ: Alzheimer's disease: The relationship between the density of senile plaques, neurofibrillary tangles and A4 protein in human patientS, Neurosci Lett 1991;123:141-143.
11. Tomlinson BE, Blessed G, Roth M: Observations on the brains of non-demcnted old people. J Neurol Sci 1968;7:331-3546.
12. de la Torre JC, Mussivand T: Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res 1993;15:146-153.
13. de la Torre JC: Is Alzheimer's disease caused by impaired delivery of energy substrates to the brain? Neurobiol Aging 1994:15(suppl 1): S629-S630.
14. de la Torre JC: Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Behav Res 1994;18:397-401.
15. Pardridge WM: Transport of nutrients and hormones through the blood-brain barrier. Fed Proc 1984; 43:201-204.
16. Obrist WD: Non-invasive studies of cerebral blood flow in aging and dementia: in Katzman R, Terry R, Bick K (eds): Alzheimer’s Disease. Senile Dementia and Related Disorders. New York. Raven Press. 1978.
17. Lassen NA, Ingvar DH: Blood flow studies in the aging normal brain and in senile dementia: in Amaducci L, Davison AN, Antuono P (eds): Aging of the Brain and Dementia. New York. Raven Press. 1980. pp 91-98.
18. Fisher VW, Siddigi A, Yusufalv Y: Altered angioarchitccture in selected areas of brains with Alzheimer's disease. Acta Neuropathol 1990:79: 672-679.
19. Ravens JR: Vascular changes in the human senile brain: in Cervos-Na-varro J (ed): Pathology of Cerebrospinal Microcirculation. New York. Raven Press. 1978. pp 487-501.
20. Schcibcl AB, Duong T, Jacobs R: Alzheimer's disease as a capillary dementia. Ann Med 1989:21:103-107.
21. Hasslcr O: Arterial deformities in senile brains. Acta Neuropathol 1967;8:219-229.
22. Cummings JL, Tomiyasu U, Read S, Benson DF: Amnesia with hippocampal lesions after cardiopulmonary arrest. Neurology 1984:34: 679-681.
23. Tanabc H, Hashikaw A, Nagagawa Y, Ideda M: Memory loss due to transient hypoperfusion in the medial temporal lobes including hippocampus. Acta Neurol Scand 1991: 84:22-27.
24. Zola-Morgan S, Squire LR, Amaral D: Human amnesia and the medio-temporal region: Enduring memory impairment following a bilateral lesion limited to field CAI of the hippocampus. J Neurosci 1986:6:2950-2967.
25. Pcrlmutter LS, Myers MA, Barron E: Vascular basement membrane components and the lesions of Alzheimer's disease. Micros Res Tech 1994:28:204-215.
26. Yamashita K, Miyakawa T, Katsu-ragi S: Vascular changes in the brains of Alzheimer’s disease. Jpn J Psych iatr Neurol 1991;45:79-84.
27. Mancardi GL, Perdelli F, Leonardi A, Bugiani O: Thickening of the basement membrane of cortical capillaries in Alzheimer’s disease. Acta Neuropathol 1980:49:79-83.
28. Schcibcl AB, Duong T, Tomyasu O: Microvascular changes in Alzheimer’s disease; in: The Biological Substrates of Alzheimer’s Disease. New York. Academic Press. 1986. pp 77-192.
29. Miyakawa T, Katsuragi S, Wata-nabe K, Shimoji A, Ikeuchi Y: Ul-trastructural studies of amyloid fibrils and senile plaques in human brain. Acta Neuropathol 1986:70: 202-208.
30. Miyakawa T, Uehara Y: Observation of amyloid angiopathy and senile plaque under a scanning electron microscope. Acta Neuropathol 1979:48:153-156.
31. Miyakawa T, Kuramoto R: Ultra-structural study of senile plaques and microvessels in the brain with Alzheimer's disease and Down’s syndrome. Ann Med 1989:21:99-102.
32. Higuchi Y, Miyakawa T, Shimoji A, Katsuraji S: Ultrastructural changes of blood vessels in the cerebral cortex in Alzheimer’s disease. Jpn J Psychiatr Neurol 1987;41:283-290.
33. Kimura T, Hashimura T, Miyakawa T: Observations of microvessels in the brain of Alzheimer's disease by the scanning electron microscopy. Jpn J Psychiatr Neurol 1991:45: 671-676.
34. Kidd M: Alzheimer’s disease: An electron microscopic study. Brain 1964;87:307-320.
35. Miyakawa T, Shimoji A, Kuramoto R, Higuchi Y: The relationship between senile plaques and cerebral vessels in Alzheimer’s disease and senile dementia. Virchows Arch [B] 1982:40:121-129.
36. Mann DMA, Purkiss M, Bonshek RE, Joncs D, Brown M, Sloddart RW: Lectin histochemistry of cerebral microvessels in ageinG, Alzheimer’s disease and Down’s syndrome. Neurobiol Aging 1991:13: 137-143.
37. Kalaria RN, Hedera P: Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuro Nep 1995:6:477-480.
38. Buée L, Hof PR, Bouras C, Dela-courte A, Perl D, Morrison JH, Fillit HM: Pathological alterations of the cerebral microvasculaturc in Alzheimer’s disease and related demented Disorders. Acta Neuropathol 1994:87:469-480.
39. Vinters HV, Sccor DL, Read SL, Frazec J, Tomiyasu U, Stanky TM, Ferrciro J, Akers MA: Microvasculaturc in brain biopsy specimens from patients with Alzheimer’s disease: An immunohistochcmical and ultrastructural study. Ultrastruct Pathol 1994:18:333-348.
40. Zlocovic BV, Ghiso J, Mackic J, Weiss MH, Frangtone B: Blood-brain barrier transport of circulating Alzheimer’s amyloid beta. Biochem Biophys Res Cummun 1993:30: 1034-1040.
41. Fung YC: Biodynamics Circulation. New York. Springer. 1984.
42. Dintcnfass L: Hemorheology and the microcirculation: Role of the inversion phenomenon; in Garlick D (ed): Progress in Microcirculation Research. Sydney. University of South Wales, 1980. pp 100-140.
43. l8F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 1983:40: 711-714.
44. Hoyer S: Abnormalities of glucose metabolism in Alzheimer's disease. Ann NY Acad Sci 1991:640:53-58.
45. Hoyer S: Brain energy metabolism and its significance for Alzheimer’s disease; in Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM (eds): Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategics. New York. Wiley, 1991, pp 53-57.
46. Hoyer S: Senile dementia and Alzheimer’s disease. brain blood flow and metabolism. Prog Neuro-Psy-chopharmacol Biol Psychiatry 1986; 10:447-478.
47. Fricdland RP, Budinger T, Koss H, Ober B: Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 1985:53:235-240.
48. Frackowiak RS, Pozzilli C, Marshall J, Lcnzi G, Jones T: Regional cerebral oxygen supply and utilization in dementia: A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981:104: 753-778.
49. Marcus DL, de Leon M, Goldman J, Logan J, Christman D, Wolf A, Fowler J, Hunter K, Tsai J, Pearson J, Freedman ML: Altered glucose metabolism in microvesscls from patients with Alzheimer’s disease. Ann Neurol 1989;26:91-94.
50. Kuhl CE, Mctter E, Riege WH, Hawkins R: Patterns of cerebral glucose utilization in dementia: in Grietz T (ed): The Metabolism of the Human Brain: Studies with Positron Emission Tomography. New York. Raven Press. 1985, pp 419-431.
51. Haxby JV, Grady C, Koss E, Hor-w'itz B, Schapiro M, Fricdland RP, Rapoport SI: Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer’s type. Neurology 1988;38:1853-1863.
52. Duara R, Grady C, Haxby J: Positron emission tomography in Alzheimer’s disease. Neurology 1986; 36:879-887.
53. Mcier-Ruge W, Bertoni-Frcddari C, Iwangoff P: Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer’s disease. Gerontology 1994:40:246-252.
54. Erccinska M, Silver I: ATP and brain functioN, J Cereb Blood Flow Metab 1989;9:2-19.
55. T ucek S: Regulation of acetylcholine synthesis in the brain. J Neurochcm 1985:44:11-24.
56. Davis P, Maloney AF: Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 1986;ii: 1403.
57. Perry EK: The cholinergic hypothesis: 10 years on. Br Med Bull 1986; 42:63-69.
58. Perry EK, Tomlinson BE, Blessed G, Gergmann K, Gibson PH, Perry RH: Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978;ii: 1457-1459.
59. Landin K, Blennow K, Wallin A, Gottfries C-G: Low blood pressure and blood glucose levels in Alzheimer’s disease: Evidence for a hypo-metabolic disorder? J Intern Med 1993;233:257-363.
60. Meier-Ruge W, Iwangoff P, Bertoni-Freddaric C: What is primary and what is secondary for amyloid deposition in Alzheimer’s disease? Ann NY Acad Sci 1994;719:230-237.
61. Mattson MP: Calcium and neuronal injury in Alzheimer’s disease: Contributions of beta-amyloid precusor protein mismctabolism, free radicals and metabolic compromise. Ann NY Acad Sci 1994:747:50-76.
62. Smith-Swintosky VZ, Pettigrew LC, Culwell R, Rydel R, Mattson MP: Secreted forms of beta-amyloid precursor protein protect against ischemic injury. J Neurochem 1994;63: 781-784.
63. Meier-Ruge W, Iwangoff P, Reichl-meier K: Neurochemical enzyme changes in Alzheimer's and Pick’s disease. Arch Gerontol Gcriatr 1984;3:161-165.
64. de la Torre JC, Fortin T, Park G, Butler K, Kozlowski P, Pappas BA, de Socarraz H, Saunders JK: Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res 1992; 582:186-195.
65. Pappas BA, de la Torre JC, Davidson C, Keyes M, Fortin T: Chronic reduction of cerebral blood flow in the adult rat: Late emerging CA1 cell loss and memory function. Brain Res 1996;708:50-58.
66. de la Torre JC: Progressive neurode-gcncration in rat brain after chronic 2-VO or 3-VO; in Fiskum G (ed): Neurodegenerativc Diseases. New York. Plenum Press. 1996. pp 77-84.
67. Delacourte A: General and dramatic glial reaction in Alzheimer brains. Neurology 1990;40:33-37.
68. Duffy PE, Rapport M: Glial fibrillary acidic protein and Alzheimer-type dementia. Neurology 1980:30: 778-782.
69. Harpin ML, Delacre P, Javoy-Agid F: Glial fibrillary acidic protein and ß-A4 protein deposits in temporal lobe of aging brain and senile dementia of Alzheimer-type. J Neurosci Res 1990;27:587-594.
70. Vijayan VK, Geddes J, Anderson K, Chang-Chui H, Ellis W, Cotman CW: Astrocyte hypertrophy in the Alzheimer’s disease hippocampal formation. Exp Neurol 1991:112: 72-78.
71. Grubb R, Raichle M, Gado M, Eichling J, Hughes C: Cerebral blood flow, oxygen utilization and blood volume in dementia. Neurology 1977;27:905-910.
72. Kalaria RN: The blood-brain barrier and cerebral microcirculation in Alzheimer’s disease. Cerebrovasc Brain Metab Rev 1992:4:226-260.
73. Manning CA, Ragozzino M, Gold PE: Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer type. Neurobiol Aging 1993;14:523-528.
74. Parsons MW, Gold PE: Glucose enhancement of memory in elderly humans: An inverted-U dose-responsc curve. Neurobiol Aging 1992:13: 401-404.
75. Simpson IA, Koteswara R, Chundu MD, Davis-Hill T, Hotter W, Davies P: Decreased concentrations of GLUT I and GLUT3 glucose transporters in brains of patients with Alzheimer’s disease. Ann Neurol 1994:35:546-551.
76. Kalaria RN, Harik SI: Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer’s disease. J Neurochcm 1989;53:1083-1088.
77. Khachaturian ZS: Calcium and the aging brain: Upsetting a delicate balance? Geriatrics 1991:46:78-83.
78. Mattson MP, Engle MG, Rychlik B: Effects of elevated intracellular calcium levels on the cytoskclcton and tau in cultured human cortical neurons. Mol Chem Neuropathol 1991: 15:117-142.
79. Cheng B, Mattson MP: Glucose deprivation elicits neurofibrillary tan-glc-likc antigenic changes in hippocampus neurons: Prevention by NGF:bFGF. Exp Neurol 1992:117: 114-123.
80. Khachaturian ZS: Calcium hypothesis of Alzheimer’s disease and brain aging. Ann NY Acad Sci 1994:747: 1-11.
81. Kartsounis LD, Rudge P, Stevens JM: Bilateral lesions of CA1 and CA2 fields of the hippocampus are sufficient to cause severe amnesic syndrome in humans. J Neurol Neu-rosurg Psychiatry 1995:59:95-98.
82. Sparks DL, Hunsaker JC, Scheff S, Kryscio R, Henson JL, Markcsbcrry WR: Cortical senile plaques in coronary artery disease. aging and Alzheimer's disease. Neurobiol Aging 1990;11:601-607.
83. Jendroska K, Cervos-Navarro J, Poexve W: Deposition of beta-amy-loid associated with cerebral hypoxia. Clin Neuropathol 1993:12:252.
84. Nagata K, Shinohara T, Hatazawa J, Yokoyama E, Sato M, Satoh Y, Wa-tahiki Y, Hirata Y: Possible vascular factor underlying dementia of Alzheimer's type. Stroke 1995:26:177.
85. Sakamoto S: Studies of cerebral blood flow and metabolism in patients with senile dementia of the Alzheimer's type and diagnostic evaluation of the dementing illness by positron emission tomography. Nippon Ika Daigako Zasshi. J Nippon Med School 1995:57:222-234.
86. Yao H, Sadoshima S, Ibayashi S, Kuwabara Y, Ichiya Y, Fujishima M: Lcukoaraiosis and dementia in hypertensive patients. Stroke 1992: 23:1673-1677.
87. Kato T, Hirano A, Katagiri T, Sasaki H, Yamada S: Neurofibrillary tangle formation in the nucleus bas-alis of Meyncrt ipsilateral to a massive cerebral infarction. Ann Neurol 1988;23:620-623.
88. Gcddes JW, Schwab C, Craddock S, Wilson JL, Pettircw LC: Alterations in tau immunostaining in the rat hippocampus following transient cerebral ischemia. J Cereb Blood Flow Metab 1994;14:554-564.
89. Dewar D, Graham DL, Teasdale GM, McCulloch J: Alz-50 and ubi-quitin immunoreactivity is induced by permanent focal cerebral isch-acmia in the cat. Acta Neuropathol (Berl) 1993;86:623-629.
90. Graham DI, Gentleman SM, Lynch A, Robcts GW: Distribution of beta-amyloid protein in the brain following severe brain injury. Neuropathol Appl Neurobiol 1995;21:27-34.
91. Siman R, Card P, Nelson R, Davis LG: Expression of p-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 1989:3:275-285.
92. de la Torre JC, Butler K, Kozlowski P, Fortin T, Saunders J K: Correlates between NMR spectroscopy, diffusion weighted imaging and CA1 morphology following chronic brain ischemia. J Ncurosci Res 1995:41: 238-245.
93. Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimaya A, Kessler J, Herholz K, Ilciss WD: HMPAO, SPECT and FDG PET in Alzheimer’s disease and vascular dementia. Eur J Nucl Med 1994:21 1052-1060.
94. 90mTc-HMPAO in the investigation of dementia. J Neurol Neu-rosurg Psychiatry 1987:50:1101 -1109.
95. Houston AS, Kemp PM, McLeod MA: A method for assessing the significance of abnormalities in HMPAO brain SPECT images. J Nucl Med 1994:35:239-244.
96. 90mTc-HMPAO, a new brain imaging agent: Biodistribution studies and initial clinical trials in dementia. Nucl MedCommun 1986:7: 284-285.
97. 90mTc-HMPAO SPECT. Ncuroradiology 1994:36: 1-6.
98. Waldemar G, Bnihn P, Kristcnsen M, Johnsen A, Paulson OB, Lassen NA: Heterogeneity of neocortical cerebral blood How deficits in dementia of the Alzheimer type: A [99mTc]-d.l-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994:57:285-295.
99. Kuschinsky W, Paulson OB: Capillary circulation in the brain. Cer-ebrovasc Brain Metab Rev 1992:4: 261-286.
100. Scharrer E: The blood vessels of the nervous tissue. Q Rev Biol 1944:19:308-318.
101. Bell MA, Ball MJ: Morphometrie comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities. Acta Neuropathol 1981; 53:299-318.
102. Tachibana H, Meyer J, Okayasu H, Shaw T, Kandula P, Rogers R: Xenon contrast CT-CBF scanning of brain differentiates normal age-related changes from mulii-inlarct dementia and senile dementia of the Alzheimer type. J Gerontol 1984:39:415-423.
103. Deutsch G, Tweedy JR: Cerebral blood flow in seventy matched Alzheimer and multi-infarct patients. Neurology 1987;37:431-438.
104. Celsis P, Agniel A, Peul M, Rascol A, Vergnes J: Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type. J Neurol Neurosurg 1987:50:1602-1612.
105. Graham DL, Adams JH, Doyle D: Ischemic brain damage in fatal non-missile head injuries. J Neurol Sci 1978:39:213-234.
106. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI: Beta amyloid protein deposition in the brain alter severe head injury: Implications for the pathogenesis of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1994:57:419-425.
107. Maycux R, Oltrnan R, Maestro G, Ngai C, Tang MX, Ginsberg H, C'hun M, Tycko B, Shclanski M: Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology 1995; 555-557.
108. McKenzie JE, Gentleman SM, Roberts GW, Graham DL, Roys-ton MC: Increased numbers of beta-APP-immunoreactive neurones in the entorhinal cortex after head injury. Neuro Rep 1994:6: 161-164.
109. Corsellis JAN, Bruton CJ, Free-man-Browne D: The aftermath of boxing. Psychol Med 1973:3:270-303.
110. Corsellis JAN, Brierly JB: Observations on the pathology of insidious dementia following head injury. JMent Sci 1959;105:714-720.
111. Mawdsley C, Ferguson FR: Neurological disease in boxers. Lancet 1963;ii:795-801.
112. Martland HS: Punch drunk. JAMA 1928:91:103-107.
113. Critchley M: Medical aspects of boxing, particularly from a neurological standpoint. Br Med J 1957: i:357-362.
114. Brandenberg W, I lallervorden J: Dementia pugilistica mit anatomischem Befund. Virchows Arch 1954:325:680-709.
115. Barclay L, Zcmcor A, Reichert W: Cerebral blood flow decrements in chronic head injury syndrome. Biol Psychiatry 1985:20:146-157.
116. Terayama S, Meyer JS, Kawamura J: Cognitive recovery correlates with long-term increases of cerebral perfusion after head injury. Surg Neurol 1991;36:335-342.
117. Levin HS, Mayers LA, Grossman RG, Sarwar M: Ventricular enlargement after closed head injury. Arch Neurol 1981:38:623-629.
118. Kotapka MJ, Graham DL Adams JH, Gennarelli TA: Hippocampal pathology in fatal, non-missile human head injury. Acta Neuropa-thol 1992;83:530-534.
119. Johnson SC, Bigler E, Burr RB, Blatter DD: White matter atrophy, ventricular dilatation and intellectual functioning following traumatic brain injury. Neuropsychology 1994:8:307-315.
120. Rasmusson DX, Brandt J, Martin DB, Folstcin MF: Head injury as a risk factor in Alzheimer’s disease. Brain Injury 1995:9:213-219.
121. Paulson OB, Strandgaard S, Ed-vinsson L: Cerebral autoregulation. Brain Metab Rev 1990:2: 161-192.
122. Corder EH, Saunders AM, Stritt-mattcr WJ, Schmechcl D, Gaskcll PC, Small G, Roses AD, Haines J, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late-onset families. Science 1993: 261:921-923.
123. Saunders AM, Strittmatler WJ, Schmechcl D: Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993: 43:1467-1472.
124. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988:8:1-21.
125. Kosunen O, Talasniemi S, Lchto-virta M: Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer’s disease. Stroke 1995:743-748.
126. Wang XL, McCredie RM, Wilcken DE: Polymorphism of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterio Thromb Vase Biol 1995;8:1030-1034.
127. Frisoni G, Geroldi C, Blanchctti A, Trabucchi M, Govoni S, Fran-ceschini G, Calabresi L: Apolipoprotein Ej allele frequency in vascular dementia and Alzheimer's disease. Stroke 1994:25:1703.
128. Noguchi S, Mutakami K, Yamada N: Apolipoprotein E genotype and Alzheimer’s disease. Lancet 1993: 342:737.
129. Kalaria RN, Cohen DL, Premku-mar DRD: Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease. Ann NY Acad Sci 1996;777:266-271.
130. Botet JP, Senti M, Nogues X, Ru-bies-Prat J, Roqucr J, D’olhaber-riaguc L, Olive J: Lipoprotein and apolipoprotein profile in men with ischemic stroke. Stroke 1992:23: 1556-1562.
131. Kalaria RN, Prekumar DRD: Apolipoprotein E genotype and cerebral amyloid angiopathy. Lancet 1995:346:1424.
132. Lehtincn S, Lehtimaki T, Sisto T, Salenius J, Nikkila M, Jokcla H, Koivula T, Eberling F, Ehnholm C: Apolipoprotein E polymorphism. serum lipids, myocardial infarction and severity of angio-graphically verified coronary artery disease in men and women. Atherosclerosis 1995:114:83-91.
133. Couderc R, Mahieux F, Bailleul S: Apolipoprotein Ej allele frequency. ischemic cerebrovascular disease and Alzheimer’s disease. Stroke 1994;24:1416-1417.
134. Reed T, Carmelli D, Swan GE, Breitncr JC, Welsh KA, Jarrik GP, Dccb S, Auwerx J: Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon allele. Arch Neurol 1994:51:1189-1192.
135. Small GW, Mazziotta JC, Collins M, Baxter L, Phelps ME: Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer’s disease. JAMA 1995;273:942-947.
136. Shimano H, Ishibashi S, Murase T: Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis 1989:79:257-260.
137. Schneider JA, Gearing M, Mirra SS: Apolipoprotein E (apoE) genotype in diverse neurodegcnerative diseases. Brain Pathol 1994:4:538.
138. Venarucci D: ApoE phenotype in atheromatous plaques. Stroke 1994:25:2296-2297.
139. Kondo K, Niino M, Shido K: A case control study of Alzheimer's disease in Japan: Significance of life styles. Dementia 1994:5:314-326.
140. Dartigucs JF, Gagnon M, Michel P, Lettemcus L: The Paquid research program on the epidemiology of dementia: Methods and initial research. Rev Neurol 1991: 147:225-230.
141. Stem Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mageux R: Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA 1994;271: 1004-1010.
142. Canadian Study of Health and Aging: Risk factors for Alzheimer’s disease in Canada. Neurology 1994:44:2073-2080.
143. Dartigues JF, Gagnon M, Lettcr-ncus L, Barberger-Gateaup: Principal lifetime occupations and cognitive impairment in a French elderly cohort. Am J Epidemiol 1992:135:981-988.
144. Friberg L: Brain mapping in thinking and language function. Acta Ncurochir 1993:56 (suppl):34-39.
145. Wise R, Chollet F, Hadar U, Fris-ton K, HofTner E, Frackowiak R: Distribution of cortical neural networks involved in word comprehension and word retrieval. Brain 1991:114:1803-1807.
146. Roland PE, Friberg L: Localization of cortical areas activated by thinking. J Neuropsychol 1985;53: 1219-1243.
147. Andersen K, Launer U, Ott A, Hoes AW, Breteler MMB, Hofman A: Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? Neurology 1995:45:1441-1445.
148. McGeer PL, McGcer E, Rogers J, Sibley J: Anti-inflammatory drugs and Alzheimer’s disease. Lancet 1991:335:1037.
149. Rogers J, Kirby LC, Hempelman MR, Berry DL, McGeer PL: Clinical trial of indomcthacin in Alzheimer’s disease. Neurology 1993; 43:1609-1611.
150. Smith WL, DcWitt DL: Biochemistry of prostaglandin endoperox-ide H synthase-1 and synthase-2 and their differential susceptibility to non-steroidal anti-inflammatory drugs. Semin Nephrol 1995:15: 179-194.
151. Chemtob S, Bcharry K, Barna T, Varma BR, Aranda JV: Differences in the effects of newborn piglet of various non-steroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr Res 1991:30:106-111.
152. Fricdland RP, Marotta C, Majo-cha RE: Anti-amyloid antibodies for in vivo diagnosis of Alzheimer's disease. Neurology 1991: 41(suppl 1): 156.
153. Goldsmith HS, Bacciu P, Cossu M: Regional cerebral blood flow after omental transposition to the ischemic brain in man: A 5 year follow-up study. Acta Neurochir 1990:106:145-152.
154. Goldsmith HS: Omental transposition for Alzheimer’s disease. Neurol Res 1996:103-108.
155. de la Torre JC: Comment on omental transposition for Alzheimer’s disease. Neurol Res 1996; 18:295-296.